Home / Stocks / MDGL

MDGL insider trading

MADRIGAL PHARMACEUTICALS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$61.9M
Buys · last 90 days
0 · $0
Most recent buy
2025-08-20

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-20Taub Rebecca
Director
Sold2,238$490.77$1.1M
2026-01-13FRIEDMAN PAUL A
Director
Sold6,878$519.81$3.6M
2026-01-13Taub Rebecca
Director
Sold2,044$517.84$1.1M
2025-12-12FRIEDMAN PAUL A
Director
Sold22,043$552.28$12.2M
2025-12-12Taub Rebecca
Director
Sold16,077$552.22$8.9M
2025-12-04Sibold William John
President and CEO
Sold2,400$575.34$1.4M
2025-11-07BATE KENNETH
Director
Sold8,103$483.89$3.9M
2025-09-09Sibold William John
President and CEO
Sold7,279$445.63$3.2M
2025-08-21Sibold William John
President and CEO
Sold6,485$400.03$2.6M
2025-08-20667, L.P.
Director
Bought97,065$380.58$36.9M
2025-08-20667, L.P.
Director
Bought68,618$364.04$25.0M
2025-08-13FRIEDMAN PAUL A
Director
Sold44,526$355.36$15.8M
2025-08-13Taub Rebecca
Director
Sold44,368$355.34$15.8M
2025-08-13FRIEDMAN PAUL A
Director
Sold119,617$370.90$44.4M
2025-07-18FRIEDMAN PAUL A
Director
Sold18,176$353.59$6.4M
2025-07-18Taub Rebecca
Director
Sold18,241$353.51$6.4M
2025-03-07Waltermire Robert E.
Senior VP, Chief Pharma Dev.
Sold4,701$343.85$1.6M
2025-02-28Daly James M
Director
Sold14,302$347.39$5.0M
2025-02-28BATE KENNETH
Director
Sold12,093$356.03$4.3M
2024-11-08Levy Richard S
Director
Sold5,000$350.00$1.8M
2024-09-11Sibold William John
President and CEO
Sold6,363$243.83$1.6M

Most active insider buyers

InsiderRoleBuysTotal bought
667, L.P.Director2$61.9M

See MDGL on the chart

Every insider buy and sell for MDGL plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.